3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy]
RxNorm concept 1860172, branded drug (sbd). Prescribable name: Xultophy 100/3.6 in 3 ML Pen Injector.
- RxCUI
- 1860172
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1860172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Xultophy (insulin degludec 100 UNT / liraglutide 3.6 MG/ML) per 3 ML Pen Injector
Related concepts
- insulin degludec 100 UNT/ML (SCDC, consists of)
- liraglutide 3.6 MG/ML (SCDC, consists of)
- insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML [Xultophy] (SBDC, consists of)
- Pen Injector (DF, has dose form)
- Xultophy (BN, has ingredient)
- 3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1860172 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1860172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1860172. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.